Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06505447

PICU-related Sleep and Circadian Dysregulation Pilot Study

A Three-phase Pilot Study of the Feasibility of the Measurement and Promotion of Sleep and the Circadian Rhythm in a Pediatric Intensive Care Unit

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
State University of New York at Buffalo · Academic / Other
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Not accepted

Summary

A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restricting all provided nutrition to during daytime hours.

Detailed description

Several of the identified sleep disruptors in a pediatric intensive care environment may not be modifiable, including restricting feeding to daytime hours and providing normal daytime light exposure. This study aims to measure the feasibility of measuring sleep and circadian patterns in a PICU during routine care and during 2 focused sleep promotion interventions: timed daytime light exposure (DLE) and daytime feeding restriction (DFR). The overall objective of this study is to test the hypothesis that, with multi-disciplinary efforts, providing chronotherapeutic care will be feasible and that reliably measuring sleep patterns and the CR of critically ill children with timed salivary melatonin assays and actigraphy is possible.

Conditions

Interventions

TypeNameDescription
OTHERDaytime light exposureParticipants will be exposed to a 10,000 lux light source within 3 feet of their face/eyes to promote the natural circadian rhythm for 2-3 hours from 10am to 12/1pm depending on their nap time at home
OTHERDaytime restricted feedingParticipant's nutrition, parenteral or enteral, will be restricted to the hours when they are normally awake at home.

Timeline

Start date
2024-12-06
Primary completion
2026-12-30
Completion
2027-01-01
First posted
2024-07-17
Last updated
2026-03-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06505447. Inclusion in this directory is not an endorsement.